Eric Leip Selected Research

Diarrhea

1/2018	Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.
2/2014	Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors.
2/2012	Phase I study of bosutinib, a src/abl tyrosine kinase inhibitor, administered to patients with advanced solid tumors.
10/2011	Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric Leip Research Topics

Disease

15	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2024 - 10/2011
10	Philadelphia Chromosome 01/2024 - 10/2011
8	Leukemia 12/2023 - 04/2012
4	Blast Crisis (Blast Phase) 12/2021 - 09/2015
4	Diarrhea 01/2018 - 10/2011
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021 - 09/2015
3	Disease Progression 01/2021 - 01/2018
2	Breast Neoplasms (Breast Cancer) 04/2014 - 04/2014
2	Exanthema (Rash) 04/2012 - 02/2012
1	Hypertension (High Blood Pressure) 06/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Cardiotoxicity 01/2016
1	Fever (Fevers) 09/2015
1	Pneumonia (Pneumonitis) 09/2015
1	Neoplasms (Cancer) 02/2012
1	Vomiting 02/2012
1	Fatigue 02/2012
1	Anorexia 02/2012
1	Nausea 02/2012
1	Coronary Disease (Coronary Heart Disease) 09/2003

Drug/Important Bio-Agent (IBA)

20	bosutinibIBA 01/2024 - 10/2011
14	Imatinib Mesylate (Gleevec)FDA Link 01/2024 - 10/2011
11	Tyrosine Kinase InhibitorsIBA 01/2024 - 02/2012
6	nilotinib FDA Link 01/2024 - 04/2012
6	Dasatinib (BMS 354825)FDA Link 01/2024 - 04/2012
3	Phosphotransferases (Kinase)IBA 01/2018 - 10/2011
2	Aromatase InhibitorsIBA 04/2014 - 04/2014
2	Hormones (Hormone)IBA 04/2014 - 04/2014
1	exemestane (Aromasin)FDA Link 04/2014
1	Letrozole (Femara)FDA LinkGeneric 04/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2014
1	Adenosine Triphosphate (ATP)IBA 02/2012
1	CholesterolIBA 09/2003

Therapy/Procedure

6	Therapeutics 12/2021 - 04/2012
3	Drug Tapering 12/2021 - 02/2014
1	Aftercare (After-Treatment) 06/2021